CYDY
CytoDyn Inc.
-0.00 (-1.50%)0.20USD1.4M成交股數272M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-10-08下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 5 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | 3.6M | 650K | 1.1M | 1.9M | 938K |
| 銷售管理費用 | 2.3M | 1.7M | 1.8M | 1.7M | 1.5M | 2.3M | 1.6M | 3.1M | 2.8M | 2.3M | 2.7M | 3.0M |
| 營業利益 | −5.6M+41% | −6.3M+70% | −21.7M-197% | −4.9M-25% | −4.0M+17% | −3.7M+9% | 22.4M-586% | −6.6M+69% | −3.4M | −3.4M | −4.6M | −3.9M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −9.9M+107% | −4.7M-2% | −22.6M-218% | −5.5M-67% | −4.8M-60% | −4.8M-50% | 19.2M-266% | −16.8M+23% | −11.9M | −9.6M | −11.6M | −13.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.01 | 0.00 | -0.02-200% | 0.00-100% | 0.00-100% | 0.00-100% | 0.02-300% | -0.020% | -0.01 | -0.01 | -0.01 | -0.02 |
| 稀釋股數 | 1.29B | 1.28B | 1.26B | 1.25B | 1.23B | 1.22B | 1.20B | 970M | 982M | 959M | 924M | 832M |
資產負債表 期末餘額
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 11.9M | 15.7M | 5.0M | 9.3M | 16.4M | 21.3M | 24.9M | 3.1M | 1.4M | 147K | 2.0M | 5.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | 0 | – | – | – | – |
| 總資產 | 14.0M | 18.5M | 8.9M | 13.5M | 21.2M | 24.9M | 28.0M | 11.1M | 10.3M | 9.2M | 12.4M | 14.6M |
| 有息負債 | 38.3M | 40.5M | 42.2M | 43.8M | 45.8M | 46.1M | 45.3M | 45.0M | 44.2M | 45.9M | 44.9M | 45.4M |
| 總負債 | 124M | 123M | 129M | 113M | 114M | 114M | 113M | 128M | 130M | 124M | 129M | 122M |
| 股東權益 | −110M | −104M | −120M | −99.5M | −93.0M | −89.4M | −85.2M | −117M | −119M | −114M | −117M | −107M |
| 負債比 | 885.2% | 663.8% | 1,440.2% | 838.0% | 538.8% | 459.3% | 404.1% | 1,148.5% | 1,262.4% | 1,337.9% | 1,041.8% | 830.8% |
| 淨現金(現金 − 有息負債) | −26.5M | −24.9M | −37.2M | −34.4M | −29.4M | −24.7M | −20.4M | −41.9M | −42.8M | −45.7M | −42.8M | −40.3M |
現金流量表 單季
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | – | −2.5M | – | – | 5.4M-221% | – | – | – | −4.5M | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | 5K | 4K | 7K | 8K | 10K | 12K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | – | – | −42.7M | –% | -0.03 | – |
| FY2025 | – | – | 3.7M | –% | 0.00 | – |
| FY2024 | – | – | −49.8M | –% | -0.05 | – |
| FY2023 | 0 | -100.0% | −79.8M | –% | -0.10 | – |
| FY2022 | 266K | – | −211M | -79,255.6% | -0.31 | – |
| FY2021 | 0 | – | −176M | –% | -0.30 | −118M |
| FY2020 | – | – | −140M | –% | -0.33 | −68.8M |
| FY2019 | – | – | −60.7M | –% | -0.23 | −50.5M |